
Contact us
About company
Develops therapeutic antibodies to specific patient populations with high unmet medical needs. Its pipeline includes a portfolio of immuno-modulators and antibodies that are used alone and in strategic combinations to create disease-specific therapies that induce, enhance, or suppress the body’s immune response.
Unknown
Unknown
Not verified company